Laboratoires Euromedis Société anonyme (EPA: ALEMG)
France
· Delayed Price · Currency is EUR
4.600
-0.060 (-1.29%)
Nov 19, 2024, 4:20 PM CET
ALEMG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 31.01 | 37.43 | 54.18 | 111.9 | 193.41 | 77.08 | Upgrade
|
Other Revenue | - | - | 0 | - | -0.01 | 0.05 | Upgrade
|
Revenue | 31.01 | 37.43 | 54.18 | 111.9 | 193.4 | 77.14 | Upgrade
|
Revenue Growth (YoY) | -37.41% | -30.92% | -51.58% | -42.14% | 150.73% | 1.41% | Upgrade
|
Cost of Revenue | 28.16 | 33.86 | 35.44 | 78.41 | 129.26 | 52.21 | Upgrade
|
Gross Profit | 2.85 | 3.57 | 18.75 | 33.49 | 64.14 | 24.93 | Upgrade
|
Selling, General & Admin | 0.85 | 4.21 | 25.35 | 27.23 | 28.03 | 27.58 | Upgrade
|
Other Operating Expenses | 5 | 4.71 | -6.66 | -4.96 | -0.46 | -2.4 | Upgrade
|
Operating Expenses | 3.8 | 9.13 | 23.88 | 29.3 | 34.17 | 27.37 | Upgrade
|
Operating Income | -0.95 | -5.56 | -5.14 | 4.19 | 29.97 | -2.44 | Upgrade
|
Interest Expense | -0.25 | -0.36 | -0.37 | -0.35 | -0.46 | -0.27 | Upgrade
|
Interest & Investment Income | 27.78 | 27.78 | - | - | - | - | Upgrade
|
Earnings From Equity Investments | - | - | 0.02 | 0.02 | -0.12 | 0.14 | Upgrade
|
Currency Exchange Gain (Loss) | -0 | -0.02 | -0.03 | -0.08 | 0.58 | -0.01 | Upgrade
|
Other Non Operating Income (Expenses) | 0.05 | -0.01 | 0.25 | 0.01 | -0.39 | 0.04 | Upgrade
|
EBT Excluding Unusual Items | 26.63 | 21.83 | -5.27 | 3.79 | 29.58 | -2.53 | Upgrade
|
Impairment of Goodwill | - | - | -0.09 | - | -0.72 | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0 | Upgrade
|
Asset Writedown | 12.3 | 12.3 | -0.43 | -1.13 | -4.39 | - | Upgrade
|
Other Unusual Items | -20.53 | -20.75 | -0.19 | -0.15 | 3.92 | -0.61 | Upgrade
|
Pretax Income | 18.4 | 13.38 | -5.98 | 2.51 | 28.39 | -3.15 | Upgrade
|
Income Tax Expense | 0.26 | 0.27 | -0.04 | 0.21 | 5.53 | 0.5 | Upgrade
|
Earnings From Continuing Operations | 18.15 | 13.11 | -5.94 | 2.3 | 22.87 | -3.64 | Upgrade
|
Minority Interest in Earnings | - | - | 0.01 | -0.05 | -0.2 | -0 | Upgrade
|
Net Income | 18.15 | 13.11 | -5.93 | 2.26 | 22.66 | -3.65 | Upgrade
|
Net Income to Common | 18.15 | 13.11 | -5.93 | 2.26 | 22.66 | -3.65 | Upgrade
|
Net Income Growth | - | - | - | -90.05% | - | - | Upgrade
|
Shares Outstanding (Basic) | - | 3 | 3 | 3 | 3 | 3 | Upgrade
|
Shares Outstanding (Diluted) | - | 3 | 3 | 4 | 4 | 3 | Upgrade
|
Shares Change (YoY) | - | -5.36% | -15.98% | - | 19.87% | -0.06% | Upgrade
|
EPS (Basic) | - | 4.60 | -1.97 | 0.75 | 7.53 | -1.22 | Upgrade
|
EPS (Diluted) | - | 4.60 | -1.97 | 0.63 | 6.33 | -1.22 | Upgrade
|
EPS Growth | - | - | - | -90.05% | - | - | Upgrade
|
Free Cash Flow | - | - | -2.08 | 17.41 | 12.84 | -2.34 | Upgrade
|
Free Cash Flow Per Share | - | - | -0.69 | 4.86 | 3.58 | -0.78 | Upgrade
|
Gross Margin | 9.20% | 9.54% | 34.60% | 29.93% | 33.17% | 32.32% | Upgrade
|
Operating Margin | -3.06% | -14.85% | -9.48% | 3.75% | 15.50% | -3.16% | Upgrade
|
Profit Margin | 58.52% | 35.03% | -10.95% | 2.02% | 11.72% | -4.73% | Upgrade
|
Free Cash Flow Margin | - | - | -3.84% | 15.56% | 6.64% | -3.04% | Upgrade
|
EBITDA | -0.39 | -4.44 | -4.01 | 5.2 | 34.41 | -1.13 | Upgrade
|
EBITDA Margin | -1.24% | -11.85% | -7.41% | 4.64% | 17.79% | -1.47% | Upgrade
|
D&A For EBITDA | 0.56 | 1.12 | 1.12 | 1 | 4.44 | 1.31 | Upgrade
|
EBIT | -0.95 | -5.56 | -5.14 | 4.19 | 29.97 | -2.44 | Upgrade
|
EBIT Margin | -3.06% | -14.85% | -9.48% | 3.75% | 15.50% | -3.16% | Upgrade
|
Effective Tax Rate | 1.39% | 2.01% | - | 8.35% | 19.46% | - | Upgrade
|
Revenue as Reported | - | - | 61.35 | 117.61 | 195.62 | 80.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.